Related Experiment Video
Updated: Sep 21, 2025

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
Mycoplasmas as Host Pantropic and Specific Pathogens: Clinical Implications, Gene Transfer, Virulence Factors, and
Ali Dawood1,2,3,4, Samah Attia Algharib2,5,6, Gang Zhao1,2,4,7
1The State Key Laboratory of Agricultural Microbiology, (HZAU), Wuhan, China.
Abstract:
Mycoplasmas as economically important and pantropic pathogens can cause similar clinical diseases in different hosts by eluding host defense and establishing their niches despite their limited metabolic capacities. Besides, enormous undiscovered virulence has a fundamental role in the pathogenesis of pathogenic mycoplasmas. On the other hand, they are host-specific pathogens with some highly pathogenic members that can colonize a vast number of habitats. Reshuffling mycoplasmas genetic information and evolving rapidly is a way to avoid their host's immune system. However, currently, only a few control measures exist against some mycoplasmosis which are far from satisfaction. This review aimed to provide an updated insight into the state of mycoplasmas as pathogens by summarizing and analyzing the comprehensive progress, current challenge, and future perspectives of mycoplasmas. It covers clinical implications of mycoplasmas in humans and domestic and wild animals, virulence-related factors, the process of gene transfer and its crucial prospects, the current application and future perspectives of nanotechnology for diagnosing and curing mycoplasmosis, Mycoplasma vaccination, and protective immunity. Several questions remain unanswered and are recommended to pay close attention to. The findings would be helpful to develop new strategies for basic and applied research on mycoplasmas and facilitate the control of mycoplasmosis for humans and various species of animals.
Insights
Mycoplasmas are significant pathogens causing diseases in various hosts. This review explores their pathogenesis, challenges in control, and future strategies for managing mycoplasmosis in humans and animals.
Area of Science:
- Veterinary Medicine
- Microbiology
- Pathogen Research
Background:
- Mycoplasmas are economically important, pantropic pathogens causing diverse clinical diseases by evading host defenses.
- Despite limited metabolic capacity, they exhibit significant undiscovered virulence and host specificity, rapidly evolving to evade immune systems.
- Current control measures for mycoplasmosis are insufficient, highlighting a critical need for advanced research.
Purpose of the Study:
- To provide an updated insight into mycoplasmas as pathogens.
- To summarize progress, challenges, and future perspectives in mycoplasma research.
- To guide the development of new strategies for controlling mycoplasmosis.
Main Methods:
- Comprehensive literature review and analysis of existing research on mycoplasmas.
- Examination of clinical implications, virulence factors, and genetic information transfer.
- Exploration of nanotechnology applications, vaccination, and protective immunity.
Main Results:
- Mycoplasmas pose significant challenges due to their adaptability and rapid evolution.
- Existing knowledge gaps exist regarding virulence factors and effective control strategies.
- Nanotechnology and improved vaccination present promising avenues for future control.
Conclusions:
- Further research is crucial to understand mycoplasma pathogenesis and virulence.
- Developing novel diagnostic and therapeutic strategies, including nanotechnology and vaccines, is essential.
- Addressing unanswered questions will facilitate better control of mycoplasmosis in humans and animals.
Related Concept Videos
Bacterial Phylum Tenericutes
Microorganisms in Medicine and Therapeutics
Bacterial Phylum Chlamydiae
Modern Molecular Taxonomy
Fungal Phylum Microsporidia
Synthetic Biology
Golden rice
Golden rice is a genetically modified...

